abstract |
The present invention relates to a compound of the formula I: □ its use as an inhibitor of microsomal prostaglandin E2 synthetase-1 (mPGES-1), a pharmaceutical composition containing the same, and as a therapeutic and/or prophylactic inflammatory disease and related The use of the drug of the condition. A, M, W, R1, R2, R6, R7 have the definitions provided in this specification. |